We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cigarette smoke may be an exacerbation factor in nonalcoholic fatty liver disease via modulation of the PI3K/AKT pathway.
- Authors
Mayuko Ichimura; Akari Minami; Noriko Nakano; Yasuko Kitagishi; Toshiyuki Murai; Satoru Matsuda
- Abstract
Nonalcoholic fatty liver disease (NAFLD) characterizes a wide spectrum of pathological abnormalities ranging from simple hepatic steatosis to nonalcoholic steato-hepatitis (NASH). NAFLD may be associated with obesity and the metabolic syndrome. Metabolic syndrome is characterized by hyperglycemia and hyperinsulinemia and also contributes to NASH-associated liver fibrosis. In addition, the presence of reactive oxygen species (ROS), produced by metabolism in normal cells, is one of the most important events in both liver injury and fibrogenesis. Smoking is one of the most common reasons that ROS are produced in a cell. Accumulating evidence indicates that deregulation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway in hepatocytes is a key molecular event associated with metabolic dysfunction, including NAFLD. Subsequent hepatic stellate cell (HSC) activation is the central event during the diseases. We review recent studies on the features of the PI3K/AKT pathway and discuss the functions in the signaling pathways involved in NAFLD. The molecular mechanisms contributing to the diseases are the subject of considerable investigation, as a better understanding of the pathogenesis will lead to novel therapies and effective preventions.
- Subjects
PHYSIOLOGICAL effects of tobacco; FATTY liver; PHOSPHATIDYLINOSITOL 3-kinases; DISEASE risk factors
- Publication
AIMS Molecular Science, 2015, Vol 2, Issue 4, p427
- ISSN
2372-028X
- Publication type
Article
- DOI
10.3934/molsci.2015.4.427